Sandu Pharmaceuticals Ltd

NSE: SANDUPHQ · BSE: 524703 · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹37.00
Market cap: ₹35.75 Cr
Revenue (annual): ₹69.93 Cr
Net profit (annual): ₹1.77 Cr
P/E (TTM): 14.7×Sector 50.4×
Promoter holding: 37.79%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1 Management Change 1 Financial Results 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

12 Sep 2026 15:26 IST BSE

Management Change

Sandu Pharmaceuticals Management Change

Sandu Pharmaceuticals appointed Dr. Neeti Madan Kapre as director and Dave & Dave as statutory auditor, while announcing other board and auditor tenure changes.

Read the filing ↗